최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The American journal of drug and alcohol abuse, v.40 no.3, 2014년, pp.244 - 250
Knapp, Clifford M.
(BUPA Clinical Studies Unit
Background: Activation of Kv7 potassium channels may decrease the reactivity of mesolimbic dopaminergic neurons that are implicated in mediating the reinforcing effects of ethanol. Objectives: The objective of this study was to determine whether the administration of the Kv7 potassium channel opener...
Weiss, Friedbert, Porrino, Linda J.. Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges. The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.22, no.9, 3332-3337.
Pharmacopsychiatry Söderpalm B S87 42 2009 10.1055/s-0029-1220690
Alc Clin Exp Res Crosby SJ 36A 32 2008 10.1111/j.1530-0277.2007.00543.x
Alcohol Clin Exp Res Fish EW 81 34 2010 10.1111/j.1530-0277.2009.01069.x
Alcohol Moolten M 221 7 1990 10.1016/0741-8329(90)90008-Z
Handbook of neuroscience for the behavioral sciences Knapp C 2009
J Pharmacol Exp Ther Imperato A 219 239 1986
Alcohol Clin Exp Res Ding ZM 1571 33 2009 10.1111/j.1530-0277.2009.00985.x
Brodie, Mark S.. Increased Ethanol Excitation of Dopaminergic Neurons of the Ventral Tegmental Area After Chronic Ethanol Treatment. Alcoholism: clinical and experimental research, vol.26, no.7, 1024-1030.
Alcohol Clin Exp Res Brodie MS 1848 23 1999 10.1111/j.1530-0277.1999.tb04082.x
Gessa, G.L., Muntoni, F., Collu, M., Vargiu, L., Mereu, G.. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain research, vol.348, no.1, 201-203.
J Pharmacol Exp Ther Hansen HH 1006 318 2006 10.1124/jpet.106.106757
J Physiol Hansen HH 1823 586 2008 10.1113/jphysiol.2007.149450
Delmas, Patrick, Brown, David A.. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nature reviews. Neuroscience, vol.6, no.11, 850-862.
Eur J Neurosci Drion G 827 31 2010 10.1111/j.1460-9568.2010.07107.x
Brain Res Moore SD 222 516 1990 10.1016/0006-8993(90)90922-X
J Neurophysiol Koyama S 1977 97 2007 10.1152/jn.00270.2006
Eur J Pharmacol Hansen HH 77 570 2007 10.1016/j.ejphar.2007.05.029
Sotty, Florence, Damgaard, Trine, Montezinho, Liliana P., Mørk, Arne, Olsen, Christina K., Bundgaard, Christoffer, Husum, Henriette. Antipsychotic-Like Effect of Retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic Acid Ester], a KCNQ Potassium Channel Opener, via Modulation of Mesolimbic Dopaminergic Neurotransmission. The Journal of pharmacology and experimental therapeutics, vol.328, no.3, 951-962.
Basic Clinl Pharmacol Toxicol Jensen MM 339 109 2011 10.1111/j.1742-7843.2011.00730.x
J Neurochem Martire M 179 102 2007 10.1111/j.1471-4159.2007.04562.x
Alcohol Stromberg MF 281 15 1998 10.1016/S0741-8329(97)00131-6
Alcohol Stromberg MF 109 23 2001 10.1016/S0741-8329(00)00137-3
Eur J Pharmacol Olive MF 55 15 2002 10.1016/S0014-2999(02)01272-4
Knapp, C.M., Mercado, M., Markley, T.L., Crosby, S., Ciraulo, D.A., Kornetsky, C.. Zonisamide decreases ethanol intake in rats and mice. Pharmacology, biochemistry, and behavior, vol.87, no.1, 65-72.
Pharmacol Biochem Behav Knapp CM 474 92 2009 10.1016/j.pbb.2009.01.017
JAMA Johnson BA 1641 10 2007 10.1001/jama.298.14.1641
Arias, Albert J., Feinn, Richard, Oncken, Cheryl, Covault, Jonathan, Kranzler, Henry R.. Placebo-Controlled Trial of Zonisamide for the Treatment of Alcohol Dependence. Journal of clinical psychopharmacology, vol.30, no.3, 318-322.
Sarid-Segal, Ofra, Knapp, Clifford M., Burch, William, Richardson, Mark A., Bahtia, Sean, DeQuattro, Kimberly, Afshar, Maryam, Richambault, Courtney, Sickels, Laurie, Devine, Eric, Ciraulo, Domenic A.. The Anticonvulsant Zonisamide Reduces Ethanol Self-Administration by Risky Drinkers. The American journal of drug and alcohol abuse, vol.35, no.5, 316-319.
World Neurosurg Voges J S28.e21 80 2013 10.1016/j.wneu.2012.07.011
SAS version 9.1.3. SAS Institute Inc., Cary, NC, USA; 2002-2003
Gunthorpe, Martin J., Large, Charles H., Sankar, Raman. The mechanism of action of retigabine (ezogabine), a first‐in‐class K+ channel opener for the treatment of epilepsy. Epilepsia : the journal of the International League against Epilepsy, vol.53, no.3, 412-424.
Arzneimittelforschung Rundfeldt C 1063 50 2000
J Pharmacol Exper Ther Korsgaard MP 282 314 2005 10.1124/jpet.105.083923
Rostock, Angelika, Tober, Christine, Rundfeldt, Chris, Bartsch, Reni, Engel, Jürgen, Polymeropoulos, Emanuele E., Kutscher, Bernhard, Löscher, Wolfgang, Hönack, Dagmar, White, H.Steve, Wolf, Harold H.. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy research, vol.23, no.3, 211-223.
Hopf, F.W., Simms, J.A., Chang, S.J., Seif, T., Bartlett, S.E., Bonci, A.. Chlorzoxazone, an SK-Type Potassium Channel Activator Used in Humans, Reduces Excessive Alcohol Intake in Rats. Biological psychiatry, vol.69, no.7, 618-624.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.